No Litigation found for CNS Pharmaceuticals, Inc.
Critical Governance & Disclosure
Board, Voting & Shareholder Rights
Capital Structure & Financial Risk
Disclosure & Communications
Current report
2026-10-02
Additional definitive proxy soliciting materials and Rule 14(a)(12) material
2026-08-25
Other definitive proxy statements
2026-08-21
Initial statement of beneficial ownership of securities
2026-08-18
Statement of changes in beneficial ownership of securities
2026-08-18
No Insider Transactions found for CNS Pharmaceuticals, Inc.
TOP
View Details